Zeran Yang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Circular RNAs in diseases 2
- Angiogenesis and VEGF in Cancer 1
-
- Medical Imaging and Pathology Studies 1
- Renal cell carcinoma treatment 1
- Co-authors
- Fusheng Wu (3 shared papers)Guohong Li (2 shared papers)Xiuming Zhu (2 shared papers)Lingjiao Wu (2 shared papers)Rong Yang (1 shared paper)Qiangfeng Wang (1 shared paper)Jie Xu (1 shared paper)Ye Cui (5 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Cancer Biology & Therapy (2 papers)BMC Pharmacology and Toxicology (1 paper)Critical Reviews in Oncology/Hematology (1 paper)World Neurosurgery (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Zeran Yang
16 papers receiving 550 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 252
- Hepatology 49
- Molecular Biology 284
- Obstetrics and Gynecology 25
- Internal Medicine 10
Countries citing papers authored by Zeran Yang
This map shows the geographic impact of Zeran Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeran Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeran Yang more than expected).
Fields of papers citing papers by Zeran Yang
This network shows the impact of papers produced by Zeran Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeran Yang. The network helps show where Zeran Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zeran Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 184 | |
| 2 | 2009 | 139 | |
| 3 | 2013 | 48 | |
| 4 | 2016 | 45 | |
| 5 | 2017 | 41 | |
| 6 | 2018 | 38 | |
| 7 | 2020 | 20 | |
| 8 | 2007 | 16 | |
| 9 | 2018 | 10 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2020 | 1 | |
| 14 | [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion]. | 2006 | 1 |
| 15 | 2024 | 1 | |
| 16 | 2022 | 1 |
About Zeran Yang
Zeran Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Hepatology, having authored 16 papers that have together received 555 indexed citations. Recurring topics across this work include Circular RNAs in diseases (2 papers), MicroRNA in disease regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Medical Imaging and Pathology Studies (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Cancer Research (252 citations), Hepatology (49 citations), Molecular Biology (284 citations), Obstetrics and Gynecology (25 citations) and Internal Medicine (10 citations). Zeran Yang has collaborated with scholars based in China and United States. Frequent co-authors include Fusheng Wu, Guohong Li, Xiuming Zhu, Lingjiao Wu, Rong Yang, Qiangfeng Wang, Jie Xu, Ye Cui, Tianhao Su and Hui‐Fang Wang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Biology & Therapy, BMC Pharmacology and Toxicology, Critical Reviews in Oncology/Hematology and World Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.